 |
인쇄하기
취소
|
Maxmavil, Amlodipin Receive Korea New Drug Awards
The Korea Drug Research Association (KDRA) selected Maxmavil by Yuyu Inc. and Amlodipin by Hanmi Pharmaceutical as the Korea New Drug Award recipients, where the award ceremony was held last week at the Seoul National University.
Maxmavil is a novel combination drug for treatment of osteoporosis, which is formulated with alendronate and calcitrol. In January, Yuyu successfully received the ...
Maxmavil is a novel combination drug for treatment of osteoporosis, which is formulated with alendronate and calcitrol. In January, Yuyu successfully received the ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.